论文部分内容阅读
近年来,全量肝素治疗重症肺炎及支气管哮喘,在国内广泛应用于临床,收效较大。但小剂量肝素治疗支气管哮喘报道较少。我院于1995年2月～1996年8月间应用小剂量肝素治疗支气管哮喘收到显著效果。现分析如下:1 临床资料选择的病例均符合1993年全国儿童哮喘研讨会制定的诊断标准。小剂量肝素治疗组74人,合并心衰46人,呼衰32人,吸氧人数40人。对照组70人,合并心衰38人,呼衰30人,吸氧人数36人。男女比例2∶1,年龄3～11岁。两组临床资料基本相同。
In recent years, the full amount of heparin for the treatment of severe pneumonia and bronchial asthma, widely used in clinical practice, the greater the effect. However, low-dose heparin treatment of bronchial asthma less reported. Our hospital in February 1995 ~ August 1996 application of low-dose heparin treatment of bronchial asthma received a significant effect. Are analyzed as follows: 1 clinical data selected cases are in line with the 1993 National Children’s Asthma Seminar developed diagnostic criteria. Small-dose heparin treatment group 74 people, with 46 heart failure, respiratory failure 32, oxygen inhalation number 40. Control group of 70 people, with 38 heart failure, respiratory failure 30 people, 36 oxygen inhalation. Male to female ratio of 2: 1, aged 3 to 11 years old. The two clinical data are basically the same.